# Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors

> **NCT01043016** · PHASE1 · UNKNOWN · sponsor: **Fujian Longhua Pharmaceutical Co. Ltd** · enrollment: 18 (estimated)

## Conditions studied

- Skin Cancer
- Esophageal Cancer

## Interventions

- **PROCEDURE:** Photodynamic therapy

## Key facts

- **NCT ID:** NCT01043016
- **Lead sponsor:** Fujian Longhua Pharmaceutical Co. Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2010-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043016, "Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01043016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*